ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · IEX Real-Time Price · USD
6.95
+0.33 (4.98%)
May 2, 2024, 4:30 PM EDT - Market closed
ESSA Pharma Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$17.00
Upside
+144.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $17 | Buy | Reiterates | $17 | +144.60% | Dec 13, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 | Buy | Reiterates | $17 | +144.60% | Aug 9, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +144.60% | Jun 26, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $50 → $20 | Buy | Maintains | $50 → $20 | +187.77% | May 12, 2022 |
| Oppenheimer | Oppenheimer | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 17, 2021 |
| Piper Sandler | Piper Sandler | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 4, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Feb 25, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Feb 11, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Mar 26, 2018 |